FOXO Technologies Inc.(formerly Delwinds Insurance Acquisition Corp.) is a technology company that aims to make longevity science the basis of life insurance. By applying epigenetic science and artificial intelligence to commercialize saliva-based biomarkers, FOXO plans to streamline the consumer underwriting process and enhance the consumer value proposition. FOXO's platform will modernize the lifestyle industry through saliva-based underwriting technology and consumer engagement services. FOXO's management team has years of combined experience in finance, health and wellness product creation and distribution, biotechnology, machine learning, software development and architecture.